Category: Medications

Medications

Antibiotic Overuse: How Misuse Fuels Resistance and C. difficile Infections

By Alan Legaspi

On Jan, 15 2026

Antibiotic overuse is driving a global crisis of drug-resistant infections and C. difficile outbreaks. Learn how misuse fuels superbugs, what’s being done, and how you can help stop the spread.

Medications

How to Prevent Moisture Damage to Pills and Capsules: Expert Storage Tips

By Alan Legaspi

On Jan, 11 2026

Learn how to protect your pills and capsules from moisture damage with expert storage tips. Discover why humidity ruins meds, how film coatings and desiccants work, and what you can do at home to keep your drugs effective.

Medications

Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs

By Alan Legaspi

On Jan, 10 2026

Big Pharma uses legal loopholes like product hopping and REMS abuse to block generic drugs from entering the market, keeping prices high. Learn how antitrust enforcement is fighting back.

Medications

Aspirin for Primary Prevention: Who Should Skip Daily Doses

By Alan Legaspi

On Jan, 8 2026

Daily aspirin for heart health is no longer recommended for most people. Learn who should skip it, why the guidelines changed, and what actually works to prevent heart attacks and strokes.

Medications

Heart Failure Medications: ACEIs, ARNI, Beta Blockers, and Diuretics Explained

By Alan Legaspi

On Jan, 5 2026

Learn how ACE inhibitors, ARNI, beta blockers, and diuretics work together to treat heart failure, reduce hospitalizations, and save lives. Evidence-based, practical, and real-world insights.

Medications

Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation

By Gemma Mondragon

On Jan, 3 2026

Learn what manufacturing changes trigger FDA re-evaluation for generic drugs, how PAS submissions work, and how to avoid costly delays. Key triggers include facility transfers, scale-up, new suppliers, and formulation changes.

Medications

Bridging Studies for NTI Generics: Ensuring Safety and Efficacy in Generic Drug Approval

By Alan Legaspi

On Dec, 25 2025

NTI generics require strict bridging studies to ensure safety, as even small differences in dosage can cause serious harm. Learn how FDA and EMA standards ensure these critical drugs are equivalent to brand-name versions.

Medications

Antiemetics and QT Prolongation: Ondansetron Risks and Safer Alternatives

By Gemma Mondragon

On Dec, 21 2025

Ondansetron effectively treats nausea but can prolong the QT interval, increasing the risk of dangerous heart rhythms. Learn when it's safe, which alternatives are better, and how to reduce cardiac risks with proper dosing and monitoring.

Medications

Frequent Urination and Urgency from Medications: Common Bladder Side Effects

By Alan Legaspi

On Dec, 15 2025

Frequent urination and urinary urgency are common but often ignored side effects of medications like diuretics, antidepressants, and blood pressure drugs. Learn which pills cause bladder problems and how to manage them without stopping treatment.

Medications

Why Generic Drugs Look Different from Brand-Name Medicines

By Alan Legaspi

On Dec, 15 2025

Generic drugs look different from brand-name pills due to U.S. trademark laws, not because they're less effective. Learn why the color, shape, or size changes - and why it doesn't affect how your medicine works.

Category: Medications - Page 3